PAPER Gavrilova SI

[Memantine in treatment of Alzheimer's disease: 20 years of clinical use].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6 Vyp 2. Neurology and psychiatry of elderly):10-18. PubMed.

PAPER Gutorova DA, Vasenina EE, Levin OS

[Screening of cognitive impairment in the old and old-old population with the 3-CT scale].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6 Vyp 2. Neurology and psychiatry of elderly):35-40. PubMed.

PAPER Kolykhalov IV

[Current approaches to optimize treatment of dementia and Alzheimer's disease].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6):87-92. PubMed.

PAPER Levin OS, Vasenina EE

[Twenty-five years of the amyloid hypothesis of alzheimer disease: advances, failures and new perspectives].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6 Vyp 2. Neurology and psychiatry of elderly):3-9. PubMed.

PAPER Likhachev SA, Rushkevich YN, Abel'skaya IS, Chechik NM, Merkul' OV

[Polysomnography in patients with amyotrophic lateral sclerosis].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(4):37-41. PubMed.

PAPER Malashenkova IK, Khailov NA, Krynsky SA, Ogurtsov DP, Kazanova GV, Velichkovsky BB, Selezneva ND, Fedorova YB, Ponomareva EV, Kolykhalov IV, Gavrilova SI, Didkovsky NA

[Levels of proinflammatory cytokines and vascular endothelial growth factor in patients with Alzheimer's disease and mild cognitive impairment].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(3):39-43. PubMed.

PAPER Odinak MM, Litvinenko IV, Emelin AY, Lobzin VY, Lupanov IA, Kolmakova KA

[Pathomorphological changes in dementia: a priority of domestic researchers].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6 Vyp 2. Neurology and psychiatry of elderly):28-34. PubMed.

PAPER Polyakova TA, Levin OS

[Cerebral microbleeds in cerebrovascular and neurodegenerative diseases with cognitive impairment].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6 Vyp 2. Neurology and psychiatry of elderly):19-27. PubMed.

PAPER Stolyarov ID, Petrov AM, Shkil'nyuk GG, Kataeva GV, Prakhova LN

[Capabilities of positron emission tomography to study mecha-nisms of multiple sclerosis: own data and literature].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(2 Pt 2):27-31. PubMed.

PAPER Tayupova GN, Saitgareeva AR, Baitimerov AR, Levin OS

[Transcranial magnetic stimulation in Parkinson's disease].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6 Vyp 2. Neurology and psychiatry of elderly):82-87. PubMed.

PAPER Timofeeva AA, Belozertseva II

[The issues of medical/social expertise in Parkinson's disease].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(9):93-97. PubMed.

PAPER Trusova NA, Levin OS, Arablinsky AV

[Clinical and neuropsychological features of Alzheimer's disease in the combination with cerebrovascular disease].

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6 Vyp 2. Neurology and psychiatry of elderly):46-53. PubMed.

PAPER Alesenko AV, Gavrilova SI, Gutner UA, Lebedeva AO, Shupik MA, Kolykhalov IV, Ponomareva EV, Selezneva ND, Fedorova YB

[Detection of effective treatment of amnestic mild cognitive impairement with cereton by testing of lipids markers].

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):21-27. PubMed.

PAPER Bogolepova AN, Zhuravleva AN, Makhnovich EV

[Perspectives of the diagnosis of Alzheimer's disease using optic coherent tomography].

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(9):112-117. PubMed.

PAPER Homenko JG, Susin DS, Kataeva GV, Irishina JA, Zavolokov IG

[Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):46-51. PubMed.